Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
TRiNDS logo — Pioneering excellence in neuromuscular and rare disease clin...

TRiNDS

Pioneering excellence in neuromuscular and rare disease clinical trials with 15+ years of specialized expertise and a patient-focused approach.

Founded 2016 United States Pittsburgh, United States 25 employees Seed

General Information

Company Name TRiNDS
Founded Year 2016
Location United States Pittsburgh, United States +1
Employees 25
Funding Stage Seed
Social

Get notified when TRiNDS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TRiNDS

TRiNDS, established in 2016, is a premier specialty contract research organization focusing on neuromuscular and rare disorders. Guided by its motto, "Pioneering excellence in neuromuscular and rare disease clinical trials with 15+ years of specialized expertise and a patient-focused approach," TRiNDS excels in providing comprehensive solutions across Clinical Operations, Data Management, and Biostatistics.

Headquartered in the United States with offices in Pittsburgh, DC, Maryland, Texas, and Washington, TRiNDS is dedicated to transforming scientific questions into viable treatments. The company collaborates closely with subject matter experts and communities to navigate the complexities of clinical trials, ensuring a tailored approach to each project.

Their last significant financial milestone was a Venture Round investment from CureDuchenne Ventures on December 19, 2016. With a patient-centric ethos, TRiNDS stands as a reliable partner for investors seeking to impact the neuromuscular and rare disorder landscape positively.

Taxonomy: Neuromuscular Disorders, Rare Disease Research, Clinical Trials, Contract Research Organization, Therapeutic Research, Clinical Operations, Patient Science Liaison, Biostatistics, Study Outcomes and Measurements, Drug Development, Duchenne Muscular Dystrophy, Pompe Disease, Pharmaceutical Research, Biotechnology Support

Services & Products

Clinical Operations
Trial Management
Site Management
Clinical Monitoring
Data Management
Study Outcome Measures

Target Customers

Pharmaceutical and Biotech Companies Academic Institutions Clinical Researchers Healthcare Providers Neuromuscular Specialists

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• - 01 Dec 2016

TRiNDS Alternatives & Competitors

TRiNDS vs
UMC Utrecht Brain Center
UMC Utrecht Brain Center The Netherlands

Internationally recognized research center in clinical and experimental neuroscience

Grant
74 employees
Health Care
Compare TRiNDS vs UMC Utrecht Brain Center
TRiNDS vs
Rare Disease Research, LLC
Rare Disease Research, LLC United States

Independent clinical research sites for rare disease clinical trials.

52 employees
Biotechnology
Compare TRiNDS vs Rare Disease Research, LLC
TRiNDS vs
Emmes' Rare Disease and Pediatric Center
Emmes' Rare Disease and Pediatric Center United Kingdom

Emmes' Rare Disease and Pediatric Center: dedicated to global clinical development for rare diseases

27 employees
Biotechnology
Compare TRiNDS vs Emmes' Rare Disease and Pediatric Center

FAQ About TRiNDS

Pioneering excellence in neuromuscular and rare disease clinical trials with 15+ years of specialized expertise and a patient-focused approach.
TRiNDS was founded in 2016.
TRiNDS is headquartered in Pittsburgh, United States.
TRiNDS has approximately 25 employees.
TRiNDS has completed 1 funding round. The latest funding stage is Seed.
TRiNDS offers: Clinical Operations, Trial Management, Site Management, Clinical Monitoring, Data Management, Study Outcome Measures.
Top alternatives and competitors to TRiNDS include UMC Utrecht Brain Center, Rare Disease Research, LLC, Emmes' Rare Disease and Pediatric Center, Synergy Clinical Research, NMD Pharma A/S. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TRiNDS and UMC Utrecht Brain Center are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TRiNDS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy